BRCA1和BRCA2致病变异相关的癌症风险
该研究基于BRCA1/2修饰因子研究者联盟中3184个BRCA1家族和2157个BRCA2家族的数据,估计22种首发原发癌的年龄别相对风险和绝对风险。BRCA1致病变异与男性乳腺癌、胰腺癌和胃癌风险升高相关;BRCA2致病变异与男性乳腺癌、胃癌、胰腺癌和前列腺癌风险升高相关。研究估计的年龄别风险有助于优化BRCA1/2致病变异携带者的癌症风险管理。
要点
- BRCA1致病变异与男性乳腺癌(RR=4.30)、胰腺癌(RR=2.36)和胃癌(RR=2.17)风险升高相关。
- BRCA2致病变异与男性乳腺癌(RR=44.0)、胃癌(RR=3.69)、胰腺癌(RR=3.34)和前列腺癌(RR=2.22)风险升高相关。
- BRCA2致病变异携带者中女性胃癌RR高于男性(6.89 vs 2.76,P=.04)。
核心结论
- 除女性乳腺癌和卵巢癌外,BRCA1和BRCA2致病变异还与男性乳腺癌、胰腺癌、胃癌以及仅BRCA2致病变异与前列腺癌风险升高相关,但与既往提示的其他癌症风险无关。
- 估计的年龄别风险将改进BRCA1/2致病变异携带者的癌症风险管理。
研究设计与样本
- 研究使用BRCA1/2修饰因子研究者联盟中3184个BRCA1家族和2157个BRCA2家族的数据,估计22种首发原发癌的年龄别相对风险和绝对风险,并对家族 ascertainment 进行调整。
主要发现
- BRCA1致病变异与男性乳腺癌(RR=4.30;95%CI,1.09至16.96)、胰腺癌(RR=2.36;95%CI,1.51至3.68)和胃癌(RR=2.17;95%CI,1.25至3.77)风险相关,也提示与结直肠癌和胆囊癌相关。
- BRCA2致病变异与男性乳腺癌(RR=44.0;95%CI,21.3至90.9)、胃癌(RR=3.69;95%CI,2.40至5.67)、胰腺癌(RR=3.34;95%CI,2.21至5.06)和前列腺癌(RR=2.22;95%CI,1.63至3.03)风险相关。
- BRCA2致病变异携带者中女性胃癌RR高于男性(6.89 vs 2.76;P=.04)。
- BRCA1携带者至80岁的绝对风险从男性乳腺癌的0.4%到胰腺癌的约2.5%;BRCA2携带者从胰腺癌的约2.5%到前列腺癌的27%。
关键数值与推荐
- BRCA1致病变异:男性乳腺癌RR=4.30(95%CI,1.09至16.96);胰腺癌RR=2.36(95%CI,1.51至3.68);胃癌RR=2.17(95%CI,1.25至3.77)。
- BRCA2致病变异:男性乳腺癌RR=44.0(95%CI,21.3至90.9);胃癌RR=3.69(95%CI,2.40至5.67);胰腺癌RR=3.34(95%CI,2.21至5.06);前列腺癌RR=2.22(95%CI,1.63至3.03)。
- BRCA2致病变异携带者胃癌RR女性6.89 vs 男性2.76(P=.04)。
- BRCA1携带者至80岁绝对风险:男性乳腺癌0.4%至胰腺癌约2.5%;BRCA2携带者:胰腺癌约2.5%至前列腺癌27%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To provide precise age-specific risk estimates of cancers other than female breast and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for effective cancer risk management. METHODS: We used data from 3,184 BRCA1 and 2,157 BRCA2 families in the Consortium of Investigators of Modifiers of BRCA1/2 to estimate age-specific relative (RR) and absolute risks for 22 first primary cancer types adjusting for family ascertainment. RESULTS: BRCA1 PVs were associated with risks of male breast (RR = 4.30; 95% CI, 1.09 to 16.96), pancreatic (RR = 2.36; 95% CI, 1.51 to 3.68), and stomach (RR = 2.17; 95% CI, 1.25 to 3.77) cancers. Associations with colorectal and gallbladder cancers were also suggested. BRCA2 PVs were associated with risks of male breast (RR = 44.0; 95% CI, 21.3 to 90.9), stomach (RR = 3.69; 95% CI, 2.40 to 5.67), pancreatic (RR = 3.34; 95% CI, 2.21 to 5.06), and prostate (RR = 2.22; 95% CI, 1.63 to 3.03) cancers. The stomach cancer RR was higher for females than males (6.89 v 2.76; P = .04). The absolute risks to age 80 years ranged from 0.4% for male breast cancer to approximately 2.5% for pancreatic cancer for BRCA1 carriers and from approximately 2.5% for pancreatic cancer to 27% for prostate cancer for BRCA2 carriers. CONCLUSION: In addition to female breast and ovarian cancers, BRCA1 and BRCA2 PVs are associated with increased risks of male breast, pancreatic, stomach, and prostate (only BRCA2 PVs) cancers, but not with the risks of other previously suggested cancers. The estimated age-specific risks will refine cancer risk management in men and women with BRCA1/2 PVs.
引用
- Li S, Silvestri V, Leslie G, et al. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. J Clin Oncol. 2022. PMID: 35077220. doi:10.1200/JCO.21.02112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。